Why the Certificate of Analysis Is Your First Line of Quality Control
Before any research peptide is weighed, reconstituted, or introduced to an experimental system, the Certificate of Analysis (COA) should be read in full. A COA is a batch-specific document issued by the manufacturer that summarizes the analytical test results for a given lot of peptide. It is the primary tool researchers use to verify that a compound meets the specifications required for reproducible, trustworthy in vitro or in vivo studies.
Understanding every field on a COA is not merely good laboratory housekeeping—it is a prerequisite for sound experimental design. An incorrectly interpreted purity value, for example, can lead to significant dosing errors in cell-based assays, skewed dose-response curves, or false-positive and false-negative results. This guide walks through each major section of a standard research peptide COA and explains what the data means in practice.
Compound Identification Fields
The top section of any COA contains identifying information that links the document to a specific batch of material. Researchers should verify each of these fields before proceeding.
- Peptide name and sequence: The full amino-acid sequence should be listed using standard single-letter or three-letter codes. Confirm this matches your order specification exactly, including any modifications such as N-terminal acetylation, C-terminal amidation, disulfide bridges, or PEGylation.
- Catalog and lot number: The lot number ties the COA to a single manufacturing batch. Always record this number in your laboratory notebook alongside experimental data for traceability.
- Molecular formula and molecular weight: These values are calculated from the sequence and any modifications. Cross-reference the stated molecular weight against an independent calculator to catch typographical errors or unreported modifications.
- CAS number (if applicable): Not all synthetic peptides carry a CAS number, but when one is listed it provides an additional verification layer.
Purity: The Most Critical Specification
Purity is almost universally the most scrutinized value on a peptide COA, and for good reason. Purity is typically expressed as a percentage and is determined by reverse-phase high-performance liquid chromatography (RP-HPLC), the gold standard analytical method for peptide purity assessment.
In RP-HPLC, the peptide mixture is separated over a nonpolar stationary phase under a gradient of increasing organic solvent. Detection is performed by UV absorbance, most commonly at 220 nm, which captures the peptide bond, or at 254 nm when aromatic residues are present. The purity percentage represents the area under the target peak divided by the total chromatogram area, multiplied by 100.
Interpreting Purity Grades
- ≥95% purity: Standard for most cell-based and biochemical assays. Impurities at this level are typically truncated sequences, deletion peptides, or oxidation products that may or may not affect the target biological readout.
- ≥98% purity: Recommended for structural studies, receptor-binding assays where minor sequence variants could compete at the binding site, or any work where impurity profiling is critical.
- <90% purity: Generally considered research grade or crude. Appropriate for preliminary screening but problematic for quantitative studies without further purification.
A well-documented COA will include the actual HPLC chromatogram or at minimum the retention time of the main peak, enabling the researcher to assess peak symmetry and the relative size of any visible impurity peaks.
Mass Spectrometry: Confirming Molecular Identity
Purity alone does not confirm identity. A peptide sample could be >95% pure yet consist predominantly of a truncated or scrambled sequence. Mass spectrometry (MS) is the definitive identity confirmation tool used in peptide quality control.
The COA should report the observed mass alongside the theoretical molecular mass calculated from the sequence. Electrospray ionization mass spectrometry (ESI-MS) is most commonly employed because it produces multiply charged ions that allow detection of high-molecular-weight peptides within typical instrument mass ranges. Matrix-assisted laser desorption/ionization (MALDI-MS) is an alternative, particularly useful for larger peptides.
Acceptable identity confirmation requires that the observed mass matches the theoretical mass within the instrument's specified tolerance, typically ±0.1 Da for ESI-MS or within a defined parts-per-million (ppm) window. Researchers should also note whether multiple charge states are reported, which provides additional confidence in the measurement. If only a single charge state is shown, the identification is less robust than a spectrum with two or more consistent charge states.
Water Content and Net Peptide Content
One of the most frequently overlooked COA fields is water content, yet it directly affects how accurately a researcher can prepare stock solutions of a defined molar concentration.
Lyophilized peptides are hygroscopic and may contain significant quantities of residual water and counterion salts (commonly trifluoroacetate from HPLC purification, or acetate after salt exchange). Water content is measured by Karl Fischer titration, an electrochemical method specific for water. Counterion content may be measured by ion chromatography or titration.
Net peptide content (NPC) is the corrected mass percentage of actual peptide after subtracting water and counterion mass from the gross weight. A vial labeled as containing 5 mg of peptide with an NPC of 70% contains only 3.5 mg of true peptide. Failing to apply this correction will result in solutions that are systematically under-concentrated relative to the intended nominal concentration.
Practical Calculation
To determine the true peptide mass in a vial: multiply the labeled gross weight by the NPC expressed as a decimal. Use this corrected mass when calculating molar concentrations for reconstitution.
Additional Analytical Fields
Depending on the supplier and peptide complexity, a COA may include several additional analytical parameters:
- Appearance: A physical description (e.g., white to off-white lyophilized powder) provides a basic visual check upon receipt.
- Solubility: Some COAs document empirical solubility testing results in common solvents such as water, DMSO, or acetic acid, which guides initial reconstitution decisions.
- Amino acid analysis (AAA): Acid hydrolysis followed by chromatographic quantification of individual amino acids confirms composition and can corroborate NPC data.
- Endotoxin testing: For peptides intended for use in cell culture or in vivo animal studies, endotoxin levels measured by limulus amebocyte lysate (LAL) assay may be reported. Endotoxin contamination is a known confound in immunological and inflammatory research models.
- Sterility: Occasionally reported for peptides produced under aseptic conditions, though this is not universal for research-grade material.
Storage and Stability Recommendations
The COA typically closes with storage conditions and an expiry or retest date. These are not formalities. Peptides containing methionine, cysteine, or tryptophan residues are particularly susceptible to oxidative degradation, while aspartate and glutamate-containing sequences may undergo deamidation or isomerization over time. Recommended storage temperatures (typically −20°C or −80°C), desiccation requirements, and protection from light should be followed strictly. Any deviation should prompt re-analysis before use in critical experiments.
Archiving the COA with Experimental Records
Standard laboratory practice requires that a copy of the COA be archived alongside all experimental data generated using that lot of peptide. If results are ever questioned during peer review or institutional audit, the COA provides documentary evidence that the research material met defined quality criteria at the time of use. Digital copies should be stored in a redundant location, and the lot number should appear in every relevant experimental notebook entry and electronic record.
For research use only. The information presented in this article is intended solely to assist trained laboratory researchers in evaluating analytical documentation for research peptides. It does not constitute medical advice, therapeutic guidance, or endorsement of any specific use in humans or animals beyond controlled laboratory research settings.